TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
ADRX

ADARx Pharmaceuticals, Inc.

Healthcare · Biotechnology

14.00$ -1.4% vs. previous close Closing price · As of: Nov 16, 2026

Statements

Cash Flow

ADARx Pharmaceuticals, Inc. (ADRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -27 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADRX
Line item Q1 25 Q2 25 Q1 26 Q2 26
-13 313 -23 -27
0.5 0.6 0.7 0.7
1.7 1.1 0.8 1.5
1.6 331 -1.4 -3.6
0.5 1.0 0.1 0.4
0.0 0.1 0.0 0.0
1.2 50 -2.7 -5.4
-13 312 -23 -28

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?